Tech Company Financing Transactions

Aktis Oncology Funding Round

On 9/30/2024, Aktis Oncology raised $175 million in Series B funding from RA Capital Management, RTW Investments and Avidity Partners.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Undisclosed
Princeton, NJ 08540
USA

Phone

Undisclosed

Website

www.aktisoncology.com

Email Address

[email protected]

Overview

Aktis Oncology is a biotechnology company pioneering the discovery and development of a new class of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers. Founded and incubated by MPM Capital, the company has developed proprietary platforms to generate tumor targeting agents with ideal properties for alpha radiotherapy.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Todd Foley

        

Chief Executive Officer

Matthew Roden

        

Browse more venture capital transactions:

Prev: 9/30/2024: Series Entertainment venture capital transaction
Next: 9/30/2024: Craftcloud venture capital transaction

Share this article

News on VC Transactions

We report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary